Therefore, we aimed to explore the relationship between the serum reg1α level and endoscopic and clinical activity in IBD and compare the monitoring efficacy of reg1α for MH with that of CRP, especially in UC phenotype. This evidence concerns the gene REG1A and inflammatory bowel disease.